ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA42 | B | Siponimod - 0.25mg | 10630 | 114420/1 | MAYZENT | 0.25mg | 120 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 124,258,444 L.L | 2.44 | E2 | Novartis Europharm Limited | Ireland | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA42 | B | Siponimod - 0.25mg | 10629 | 114620/1 | MAYZENT | 0.25mg | 12 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 15,102,158 L.L | 19.35 | D | Novartis Europharm Limited | Ireland | 2/5/2024 | 0 |